The bullish narrative about DTX Exchange (DTX) spreading in the market has made the most successful AI crypto in 2024. While the XRP price has surged in the last 7 days, and Injective (INJ) faced minor correction, DTX Exchange (DTX) is maintaining a strong bullish rally in its ongoing presale with millions raised already and only a few days before it enters next round.
Investors Expect More Gains After XRP Price Surges 23% In a Week
The XRP price was up nearly 8% yesterday, as the remittance-based token stretched its weekly gains to a whopping 23%. If investors continue holding onto their profits, the XRP price may likely extend the rally toward the $0.74 price point. As of today, the XRP price is hovering around $0.65 with a 24-hour trading volume of $6.48 billion and a 36.85 billion market cap.
On-Chain Metrics Predict Higher Upside
XRP’s Binance exchange reserve has been trending upward since November 6. Based on data from CryptoQuant, Ripple has risen from 3.10 billion XRP to 3.17 billion XRP as of Monday, November 11. A similar upward move is also visible in the XRP Upbit exchange reserve, rising from 6.61 billion to 6.63 billion XRP.
While an increase in an asset’s exchange reserve indicates potential for price decline, the XRP price has defied the trend and rose alongside its exchange reserve balance. Meanwhile, the percentage of total XRP supply in profit has been rising steadily (growing to 85%), while its Market Value to Realized Value (MVRV) crossed 56%.
Injective (INJ) Dips 9.23% Amid Market Correction
In the last 24 hours, Injective (INJ) has fallen below critical levels. Its current price is resting at $24.03, with a 9.23% decline in one day. This decline redirects investors to a broader market correction and impacts other cryptocurrencies. Despite this setback, INJ’s market cap supports the network at $2.38 billion, while it experienced the same 9.23% slump.
The recent price movement for Injective (INJ) has resulted in improved trading activity. Injective (INJ) has witnessed a notable surge of 5.47% in trading volume, closing at $417.32 million. This spike in trading volume indicates heightened trader interest, potentially suggesting that the dip could be seen as a buying opportunity by retail buyers and investors.
The technical indicators for Injective display a mixed outlook. The Relative Strength Index (RSI) is at 60, suggesting that Injective (INJ) is still in a neutral to slightly overbought area. This level suggests that Injective (INJ) might see further corrective moves or consolidation before resuming any upward momentum if it is able to break through the resistance levels.
DTX Exchange (DTX) Among Top Picks This Bullish Cycle
DTX Exchange (DTX) has successfully ranked as a top pick among investors and retail traders in the upcoming bullish cycle. As a layer-1 protocol, DTX Exchange offers over 120,000 assets across crypto, forex, stocks, and commodities. This all-in-one platform provides premium access to a vast selection of instruments, making it a one-stop destination for traders who want variety and flexibility.
Whether it’s an experienced trader or a newcomer, this deFi project offers limitless opportunities to diversify portfolios and maximize investment potential with its insane trading options. DTX Exchange enables users to claim 1,000x leverage within the platform. It lets traders control large positions with minimal capital, allowing members to bag massive profits.
Early Investment In This DeFi Platform Could Make You Millions!
DTX Exchange’s extreme leverage feature equips users to make booming returns from minimal price movements, allowing traders to 25x their gains with a smaller upfront investment. With DTX Exchange, traders can upscale their trading strategies and positions to capture high-value market movements with confidence and precision.
As Injective and Ripple show mixed signals amid the broader market sentiment shift, DTX Exchange (DTX) is leading the market with its strong presale collection that reached $7.33 million today. Join now!
Learn more:
